Session » Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy III: Biosimilars
-
Abstract Number: 2054
Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
-
Abstract Number: 2057
Antibodies to Infliximab in Remicade-Treated Rheumatic Patients Show Identical Reactivity Towards Biosimilars